Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.

Su, Ting-Shi; Lu, Huan-Zhen; Cheng, Tao; Zhou, Ying; Huang, Yong; Gao, Ying-Chuan; Tang, Min-Yang; Jiang, Hua-Yan; Lian, Zu-Ping; Hou, En-Cun; Liang, Ping

Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.

Su, Ting-Shi; Lu, Huan-Zhen; Cheng, Tao; Zhou, Ying; Huang, Yong; Gao, Ying-Chuan; Tang, Min-Yang; Jiang, Hua-Yan; Lian, Zu-Ping; Hou, En-Cun; Liang, Ping.

Afiliação

Su TS; Department of Radiation Oncology, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning, 530001, Guangxi Zhuang Autonomous Region, China. sutingshi@163.com.
Lu HZ; Cyberknife Center, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning, 530001, Guangxi Zhuang Autonomous Region, China. sutingshi@163.com.
Cheng T; Cyberknife Center, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning, 530001, Guangxi Zhuang Autonomous Region, China.
Zhou Y; Cyberknife Center, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning, 530001, Guangxi Zhuang Autonomous Region, China.
Huang Y; Department of Radiation Oncology, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning, 530001, Guangxi Zhuang Autonomous Region, China.
Gao YC; Department of Radiation Oncology, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning, 530001, Guangxi Zhuang Autonomous Region, China.
Tang MY; Department of Radiation Oncology, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning, 530001, Guangxi Zhuang Autonomous Region, China.
Jiang HY; Department of Radiation Oncology, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning, 530001, Guangxi Zhuang Autonomous Region, China.
Lian ZP; Department of Radiation Oncology, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning, 530001, Guangxi Zhuang Autonomous Region, China.
Hou EC; Department of Medical Oncology, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning, 530001, Guangxi Zhuang Autonomous Region, China.
Liang P; Department of Medical Oncology, Rui Kang Hospital, Guangxi Traditional Chinese Medical University, Nanning, 530001, Guangxi Zhuang Autonomous Region, China.

BMC Cancer ; 16(1): 834, 2016 11 03.

Article em En | MEDLINE | ID: mdl-27809890

Assuntos

Carcinoma Hepatocelular/mortalidade; Embolização Terapêutica/métodos; Neoplasias Hepáticas/mortalidade; Radiocirurgia/métodos; Adulto; Idoso; Idoso de 80 Anos ou mais; Carcinoma Hepatocelular/terapia; Terapia Combinada; Feminino; Seguimentos; Humanos; Neoplasias Hepáticas/terapia; Masculino; Pessoa de Meia-Idade; Estadiamento de Neoplasias; Prognóstico; Estudos Retrospectivos; Taxa de Sobrevida; Adulto Jovem

Palavras-chave

HCC; Hepatocellular carcinoma; SBRT; Stereotactic body radiation therapy; TAE/TACE

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radiocirurgia / Carcinoma Hepatocelular / Embolização Terapêutica / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google